| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| cd47 antibody trial | 0.17 | 0.7 | 415 | 77 | 19 |
| cd47 | 1.66 | 0.6 | 2663 | 67 | 4 |
| antibody | 1.16 | 0.5 | 1875 | 77 | 8 |
| trial | 1.99 | 0.9 | 5665 | 44 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| cd47 antibody trial | 1.59 | 0.5 | 4353 | 25 |
| cd47 antibody clinical trial | 0.79 | 0.7 | 8395 | 16 |
| anti cd47 antibody clinical trial | 0.15 | 0.3 | 9289 | 7 |
| anti cd47 antibody drug | 0.75 | 1 | 9818 | 23 |
| anti-cd47 antibody | 1.28 | 0.3 | 9275 | 96 |
| anti mouse cd47 antibody | 0.89 | 0.7 | 9683 | 99 |
| cd24 antibody clinical trial | 1.56 | 0.4 | 13 | 62 |
| anti cd40 antibody clinical trial | 1.67 | 1 | 7934 | 35 |
| targeting cd47 for cancer immunotherapy | 1.5 | 0.7 | 1912 | 25 |
| anti-cd47 fda approved | 1.9 | 0.6 | 2386 | 67 |
| anti cd47 antibody magrolimab | 0.47 | 1 | 9293 | 60 |
| anti-cd47 | 0.94 | 0.6 | 8440 | 48 |
| role of cd47 in hematological malignancies | 0.05 | 0.7 | 719 | 57 |
| human cd25 antibody clinical trials | 0.6 | 0.4 | 9055 | 22 |
| cd47 red blood cell | 0.61 | 0.8 | 1100 | 41 |
| anti-mouse cd47 | 0.71 | 0.3 | 6036 | 33 |
| cd47/cd20 | 0.01 | 0.9 | 6492 | 39 |
| cd20 cd19 cd47 autoimmune lupus | 1.38 | 0.4 | 624 | 16 |
| anti cd14 clinical trial | 1.94 | 0.2 | 4706 | 16 |
| anti-cd47 mab | 0.77 | 1 | 2057 | 77 |
| anti-cd48 phase i trial | 1.53 | 0.6 | 8785 | 74 |
| binding mechanism of cd47 | 0.34 | 0.5 | 5214 | 81 |
| cd20/cd47 | 0.25 | 0.9 | 9956 | 38 |
| leukocyte surface antigen cd47 | 1.81 | 0.2 | 3080 | 85 |
| cd47-ecd | 1.35 | 0.4 | 9565 | 74 |
